As biomedical research continues to deepen, the demand for cytokines and other biomarkers is increasing. With its excellent R&D strength and profound technical accumulation, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the Luminex cytokine assay platform, which, with its unique technological features and significant advantages, has demonstrated strong application potential and value in biomedical research.
Highly sensitive multi-parameter detection capability:
Luminex cytokine detection platform adopts advanced xMAP technology, which couples highly specific capture monoclonal antibodies to different fluorescent labeled magnetic beads to achieve simultaneous detection of multiple cytokines. This technology not only improves the sensitivity of the assay, but also greatly reduces the experiment time and meets the demand for high-throughput, multi-indicator assays. The platform is capable of detecting a variety of molecules including cytokines, growth factors, cancer markers and other molecules, providing comprehensive data support for researchers.
Personalized assay chip customization:
The Luminex cytokine detection platform is highly flexible and customizable. According to the specific needs of researchers, personalized test chips can be customized to achieve accurate detection of specific cytokines. This customized service not only meets the individual needs of researchers, but also saves experimental costs and improves research efficiency.

Double Antibody Sandwich & Fluorescence Assay:
Luminex cytokine assay platform adopts double antibody sandwich & fluorescence assay, which effectively improves the accuracy and reliability of the assay. The technology utilizes a gradient dilution of the standard detection signal to construct a standard curve, realizing the simultaneous detection and accurate quantification of multiple factors in the target sample. In addition, the platform also has a low lower limit of detection, capable of detecting cytokines at the pg/mL level to meet the needs of micro-indicator detection.
Wide sample applicability:
The Luminex cytokine platform is suitable for a wide range of biological sample types, including serum/plasma, culture supernatants and cells, tissue lysates, etc. This makes the platform suitable for a wide range of biological samples. This wide range of sample applicability allows the platform to be used in a wide range of biomedical research applications and meets the needs of different fields of research.
Avoid batch-to-batch experimental errors:
Traditional cytokine assays often suffer from batch-to-batch experimental errors, affecting the reliability of the results. Luminex cytokine detection platform adopts highly specific antibody and fluorescent labeling technology, which effectively avoids batch-to-batch experimental errors and improves the accuracy and reliability of experimental results.
Simple operation and short cycle time:
Luminex cytokine detection platform is characterized by easy operation and short experimental cycle. The researcher only needs to add the samples to be tested into the specific reagent kit, and then automate the operation on the platform to complete the test. This simple operation process and fast experimental cycle make the platform more practical and convenient in biomedical research.
In conclusion, the Luminex cytokine assay platform of InnoModels Biotechnology has shown great potential and value in biomedical research due to its highly sensitive multi-parameter detection capability, customized assay chips, double anticoagulation & fluorescence assay, wide sample applicability, avoidance of inter-batch experimental errors, and easy operation and short experimental cycle. In the future, the platform will be applied and promoted in more fields, bringing more convenience and safety guarantee to people's health and life.